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1. Introduction∗ 
 (+)-Tanikolide (1, Fig. 1) and (−)-malyngolide, which are δ-
lactones with alkyl long chains and hydroxymethyl groups at C5, 
were isolated from the marine cyanobacterium Lyngbya 
majuscula collected from Tanikeli Island, Madagascar1 and the 
shallow water variety of Lyngbya Majuscula,2 respectively. 
Interestingly, the stereochemistries of these natural products are 
opposite in comparison with C5 and alkyl side chains of different 
lengths. Additionally, malyngolide possesses a methyl group at 
C2. With respect to their biological activities, tanikolide exhibits 
strong toxicity against brine shrimp and snails and malyngolide 
displays an antimicrobial activity against Mycobacterium 
smegmatis and Streptococcus pyogenes.2 Furthermore, tanikolide 
exhibits antifungal activity against Candida albicans,1 while 
malyngolide shows no activity against it.1 Since there is a clear 
difference in their biological activities in spite of their structural 
similarities, their analogues, possessing slightly different 
substituents, may lead to new promising candidates for drug 
discovery. 
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Fig. 1. Structure of (+)-tanikolide (1) and (−)-malyngolide. 
——— 
∗ Corresponding author. Tel.: +81-76-434-7555; fax: +81-76-434-
5053; e-mail: yakura@pha.u-toyama.ac.jp (T. Yakura). 
 
 In terms of potent biological activities and structural features 
of (+)-tanikolide and (−)-malyngolide, there have been a large 
number of reports on the total syntheses of these natural 
products3–13 and their analogues.6n,o One of the key steps is the 
stereoselective construction of the quaternary carbon center at C5, 
which has been accomplished using several different approaches, 
such as aldol reactions,3 allylation of ketones such as Keck 
allylation,4 addition of Grignard reagents to ketones,5 
epoxidation–epoxide opening,6 Sharpless asymmetric 
dihydroxylation,7 sigmatropic rearrangement,8 1,3-dipolar 
cycloaddition of nitronate and acrolein,9 asymmetric 
intramolecular cyclopropanation,10 bromolactonization,11 
asymmetric allylic alkylation,12 and others.13 However, most of 
these examples are application and demonstration of synthetic 
methodologies to construct a synthetically challenging quaternary 
carbon center. To the best of our knowledge, there is only one 
example of the divergent synthesis of their analogues.6n,o 
One of the most direct and powerful methods for construction 
of substituted cyclic ethers is tandem intramolecular oxonium 
ylide formation from a-diazocarbonyl compounds under catalysis 
by dirhodium(II) or copper complexes and [2,3]-sigmatropic 
rearrangement.14 The synthetic utility of the tandem reaction has 
been demonstrated through the synthesis of a wide range of 
natural products.15 We have reported a stereoselective, copper-
catalyzed oxonium ylide formation–rearrangement of a-diazo 
ketone for the synthesis of the C3–C12 portion of laulimalide.16 
We have also disclosed that a dirhodium(II)-catalyzed tandem 
reaction of diazoketoesters proceeds with excellent 
stereoselectivity17 and is applicable to the synthesis of 2-epi-
cinatrin C1 dimethyl ester.18 As a part of our work in the 
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In this study, we described the divergent synthesis of (+)-tanikolide and its analogues, such as 
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because the long side chain can be introduced at a later stage in the synthesis. 
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development of oxonium ylide rearrangement and its application 
to the synthesis of biologically active compounds, we herein 
report a divergent synthesis of (+)-tanikolide and its analogues, 
such as 4-hydroxy- and nortanikolides.19 
2. Results and discussion 
2.1 Synthetic strategy 
Our synthetic plan for (+)-tanikolide (1) and its analogues, 4-
hydroxytanikolides (2), and nortanikolide (3), is illustrated in 
Scheme 1. We have already reported the stereoselective 
dirhodium(II)-catalyzed oxonium ylide formation–[2,3]-
sigmatropic rearrangement of 5-allyloxy-2-diazo-3-
oxocarboxylate.17,20 From this observation, we can expect to 
stereoselectively obtain (2R,5S)-dihydrofuranone 6, which has 
the same configuration at C2 as that of tanikolide, by the 
dirhodium(II)-catalyzed reaction of (5S)-diazoketoester 5. The 
diazoester 5 can be prepared from (S)-L-malic acid (4). The 
obtained dihydrofuranone 6 could be a key synthetic intermediate 
for 1–3. In addition, introduction of the alkyl side chain could be 
conducted at a later stage of the synthesis using cross metathesis 
to easily synthesize analogues with various side chains. 
Deoxygenation of the keto group in 6, followed by the oxidation 
of the resultant tetrahydrofuran-5-methanol 7 (R2 = H), could 
provide tetrahydrofurfural 9. Subsequently, N-heterocyclic 
carbene (NHC)-catalyzed ring-expansion of aldehyde 9, prepared 
from the hydroxymethyl group in 7, to δ-lactone 1121 and the 
following cross metathesis would result in the completion of the 
total synthesis of 1. Reduction of ketone 6 could afford the 
alcohol 8 (R2 = OR4), which should be converted into 2 in the 
same manner as that of 7 into 1. Noranalogue 3 could be 
synthesized from 7 by an oxidative cleavage reaction22 and cross 
metathesis. Consequently, in this synthesis, the C5 
hydroxymethyl group plays the following important roles: 
construction of the C2 chiral center, ring-expansion from γ-
lactone to δ-lactone, and oxidative cleavage. 
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Scheme 1. Synthetic strategy for (+)-tanikolide (1) and its analogues 2 and 3. 
 
2.2 Total synthesis of (+)-tanikolide 
The synthesis of the key intermediate 6a from (S)-L-malic acid 
(4) was investigated as shown in Scheme 2. Conversion of 4 into 
silyloxyalcohol 14 was conducted in the usual manner.23  
Allyllation of the hydroxy group in 14 was accomplished by the 
treatment with allyl bromide, silver(I) oxide, calcium sulfate, and 
a molecular sieve (MS) 4Å for 24 h in the dark, which afforded 
allyl ether 15 in 78% yield. After the reduction of ester 15 into 
aldehyde 16 with diisobutylaluminum hydride (DIBAL-H), the 
resultant 16 was converted to diazoketoester 5a via β-ketoester 
17 by treatment of 16 with methyl diazoacetate with SnCl2 and 
subsequent diazo transfer from p-acetoamidobenzenesulfonyl 
azide (p-ABSA) to 17. The rhodium(II)-catalyzed oxonium ylide 
formation–[2,3]-sigmatropic rearrangement of 5a yielded 
dihydrofuranone 6a with perfect stereoselectivity. The reaction of 
diazoketoester 5a with 3 mol% of dirhodium(II) tetraacetate in 
refluxing dichloromethane for 5 h produced the corresponding 
dihydrofuranone 6a as the sole product in 93% yield. 
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Scheme 2. Stereoselective synthesis of key intermediate 6a. 
 
With the key synthetic intermediate 6a in hand, we next 
examined the deoxygenation of the keto group in 
dihydrofuranone 6a (Scheme 3). After conversion of 6a to 
alcohol 18 by treatment with sodium borohydride in 
tetrahydrofuran (THF), the reaction of 18 with Martin sulfurane 
or Burgess reagents did not proceed at all. Next, we examined the 
Barton–McCombie deoxygenation of alcohol 18. Treatment of 18 
with 1,1'-thiocarbonyldiimidazole in benzene under reflux 
provided the corresponding thiocarbamate 19 in 95% yield. The 
reaction of 19 with tributyltin hydride in the presence of 
azobisisobutyronitrile (AIBN) gave a complex mixture of 
products. Since all the attempts to deoxygenate 3-
hydroxytetrahydrofuran 18 were unsuccessful, direct 
deoxygenation of the ketone in 6a using Wolff−Kishner-type 
reduction24 was then investigated. Treatment of ketone 6a with 
tosylhydrazine in THF gave hydrazone 20a in 92% yield. 
According to Hutchins’ modified conditions,24b the reaction of 
20a with sodium cyanoborohydride in the presence of catalytic 
amounts of p-toluenesulfonic acid (TsOH) in N,N-
dimethyformamide (DMF) at 130 °C provided the undesired 
dihydrofuran 21a in 40% yield, without any of the desired 
product 22. This unexpected result led us to change our synthetic 
plan. The cross metathesis for extension of the alkyl side chain 
should be conducted prior to the required hydrogenation of 
dihydrofuran. The reaction of 6a with 10 equivalent of 1-decene 
in the presence of a Grubbs 2nd catalyst proceeded smoothly to 
afford alkene 23 in 88% yield. After conversion of ketone 23 into 
tosylhydrazone 20b, we then examined the reduction of 20b. The 
treatment of 20b with NaBH3CN and 0.7 equivalent of TsOH in 
DMF at 130 °C gave dihydrofuran 21b in only 37% yield. We 
assumed that the formation of 21b from 20b proceeded through a 
Bamford−Stevens-type reaction. Therefore, we next investigated 
the reaction under standard Bamford−Stevens conditions. 
However, treatment of 20b with sodium methoxide in methanol 
under reflux did not afford the product 21b. Thus, we examined 
the reaction with NaBH3CN in the absence of TsOH. 
Gratifyingly, the yield of 21b was increased (54% yield). 
Furthermore, we found that the reaction with NaBH3CN in 
refluxing DMF afforded 21b in 76% yield. Catalytic 
hydrogenation of both cyclic and side alkenes in 21b provided 
tetrahydrofuran 24 in 94% yield. 
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Scheme 3. Deoxygenation of dihydrofuranone 6a. 
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The stage was now set for ring-expansion from γ-lactone to δ-
lactone and completion of the synthesis of (+)-tanikolide (1, 
Scheme 4). Conversion of 24 into the precursor for NHC-
catalyzed ring expansion was conducted by an uneventful four-
step transformation. Hydride reduction of methyl ester 24 with 
DIBAL-H furnished a primary alcohol 25 in 89% yield. After 
protection of the hydroxyl group as its methoxymethyl (MOM) 
ether, it was desilylated with tetrabutylammonium fluoride 
(TBAF), and subsequent Swern oxidation afforded aldehyde 26. 
We then investigate the ring expansion of tetrahydrofuran to δ-
lactone 30.21 Treatment of 28 with 30 mol% of imidazolium 
catalyst 29 in the presence of 1,8-diazabicyclo[5.4.0]undec-7-ene 
(DBU) in chloroform under reflux for 7 h gave δ-lactone 30 in 
71% yield. Finally, the MOM group in 30 was deprotected under 
acidic conditions to furnish (+)-tanikolide (1), mp 39–40 °C (lit.6h 
mp 39–41 °C), [a]D24 +2.2 (c 0.65, CHCl3) {lit.1 [a]D25 +2.3 (c 
0.65, CHCl3)}, in 56% yield. 
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Scheme 4. Synthesis of (+)-tanikolide (1). 
 
2.3 Synthesis of (4S)- and (4R)-hydroxytanikolides 
Next, we synthesized (4S)- and (4R)-hydroxytanikolides (2) 
from the key intermediate dihydrofuranone 6a. Initially, we 
examined hydride reduction of 6a (Scheme 5). The reaction of 6a 
with lithium aluminum hydride in THF at 0 °C gave a mixture of 
diols (3S)- and (3R)-8a. These diastereomers could be separated 
by column chromatography on silica gel, and (3S)- and (3R)-8a 
were obtained in 52% and 37% yields, respectively. 
Stereochemical assignments of these diols were obtained from 
experiments with acetonide formation. The reaction of the major 
isomer of 8a with 2,2-dimethoxypropane using a catalytic 
amount of TsOH in benzene under reflux proceeded smoothly to 
completion within 30 min, providing acetonide 31 in 99% yield.  
Conversely, the reaction of the minor isomer of 8a under the 
same conditions did not proceed, even after 24 h. Because 
formation of a trans-fused [6.5]-bicyclic system is generally 
more difficult than that of a cis-fused one, the stereochemistries 
of the major and minor isomers 8a at C3 were determined to be S 
and R, respectively. 
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Scheme 5. Reduction of 6a with LiAlH4. 
 
With the acetonide (3S)-31 in hand, we then examined the 
synthesis of (4S)-hydroxytanikolide (2) employing NHC-
catalyzed ring expansion and cross metathesis (Scheme 6). 
Removal of the tert-butyldimethylsilyl (TBS) protecting group in 
(3S)-31 with TBAF was followed by Swern oxidation to afford 
aldehyde (3S)-32 in 87% yield. Conversion from (3S)-32 into δ-
lactone (4S)-33 was conducted under the same conditions as 
those for 28. The product (4S)-33 was obtained in 75% yield. The 
cross metathesis between alkene (4S)-33 and 1-decene (10 
equivalent) followed by hydrogenation provided (4S)-34 in 86% 
yield. Hydrolysis of acetonide (4S)-34 under acidic conditions 
furnished (4S)-hydroxytanikolide (2) in 94% yield. 
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Scheme 6. Synthesis of (4S)-hydroxytanikolide (2). 
 
Following a procedure similar to that for (3S)-8a, the diol 
(3R)-8a was converted into (4R)-hydroxytanikolide (2, Scheme 
7). Protection of the diol as the bis-MOM groups gave (3R)-35 in 
84% yield. Desilylation of TBS ether (3R)-35 with TBAF and 
subsequent Swern oxidation provided aldehyde (3R)-36 in 73% 
yield. Ring expansion of (3R)-36 using 30 mol% imidazolium 
catalyst 29 and 20 mol% DBU in toluene at 80 °C proceeded to 
completion within 10 h, providing δ-lactone (4R)-37 in 68% 
yield. The cross metathesis for the long side chain extension and 
following hydrogenation furnished (4R)-38 in 66% yield. The 
bis-MOM groups in (4R)-38 were deprotected under acidic 
conditions to afford (4R)-hydroxytanikolide (2) in 90% yield. 
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Scheme 7. Synthesis of (4R)-hydroxytanikolide (2). 
 
2.4 Synthesis of nortanikolide 
Finally, the synthesis of nortanikolide (3) from the 
tetrahydrofuran 25, which was used as a synthetic intermediate 
for (+)-tanikolide (1), was investigated (Scheme 8). After 
protection of the hydroxyl group in 25 as its benzyl (Bn) ether, 
deprotection of the TBS ether with TBAF afforded alcohol 40 in 
84% yield. Then, we examined the oxidative cleavage of 
tetrahydrofuran-5-methanol 40 to γ-lactone. In our previous 
report on the synthesis of 2-epi-cinatrin C1 dimethyl ester, we 
employed the oxidative cleavage of tetrahydrofuran-5-methanol 
to γ-lactone with an excess amount of pyridinium dichromate and 
acetic anhydride in CH2Cl2−DMF under reflux.18 Although the γ-
lactone was obtained in good yield, the reaction was carried out 
under harsh conditions, such as the use of highly toxic hexavalent 
chromium oxidants and heating at high temperature. To avoid 
these drawbacks, we recently developed an environmentally 
benign method for oxidative cleavage using a 2-iodobenzamide 
catalyst 41.22 Therefore, we examined the oxidative cleavage 
under our original conditions. The reaction of 40 with 30 mol% 
41 and 5 equivalent of Oxone in DMF at room temperature 
provided the corresponding γ-lactone 42 in 65% yield; however, 
unexpectedly, benzoate 43 was obtained in 12% yield. This result 
indicates that the oxidation at the benzylic position of 40 
proceeded in part to give 43.25 To prevent this undesired 
oxidation, we explored the use of an antioxidant. As expected, 
the reaction of 40 using 30 mol% 2,6-di-tert-butyl-4-
hydroxytoluene (BHT) as an antioxidant suppressed the 
formation of benzoate 43 and afforded 42 in 83% yield. Finally, 
hydrogenolysis of the benzyl ether in the presence of Pearlman’s 
catalyst (Pd(OH)2/C) in methanol furnished nortanikolide (3) in 
94% yield. 
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Scheme 8. Synthesis of nortanikolide (3). 
 
3. Conclusion 
The divergent synthesis of (+)-tanikolide, (4S)- and (4R)-
hydroxytanikolides, and nortanikolide from the key intermediate 
franone was achieved. The key steps involved a rhodium(II)-
catalyzed oxonium ylide formation–[2,3]-sigmatropic 
rearrangement, an NHC-catalyzed ring expansion of 
tetrahydrofurfural to δ-lactone, or an oxidative cleavage of 
tetrahydrofuran-5-methanol to γ-lactone using a 2-iodobenzamide 
catalyst. As the quaternary chiral center can be easily and 
stereoselectively constructed, the long side chain can be 
introduced at a later stage in the synthesis, and δ- and γ-lactone 
rings can be formed from the common intermediate, the present 
protocol provides high flexibility for the synthesis of a variety of 
analogues. 
4. Experimental section 
4.1. General 
Melting points were determined using a Yanaco micro melting 
point apparatus and are uncorrected. Optical rotations were 
determined using a JASCO P-2100 polarimeter. Infrared (IR) 
spectra were recorded on a JASCO FT/IR-460 Plus 
spectrophotometer and absorbance bands are reported in 
wavenumber (cm−1). 1H NMR spectra were recorded on JEOL 
JNM-ECX400P (400 MHz) spectrometer. Chemical shifts are 
reported relative to internal standard (tetramethylsilane at δH 0.00 
or CDCl3 at δH 7.26). Data are presented as follows: chemical 
shift (δ, ppm), multiplicity (s = singlet, d = doublet, t = triplet, 
quint = quintet, m = multiplet, br = broad), coupling constant and 
integration. 13C NMR spectra were recorded on JEOL JNM-
ECX400P (100 MHz) spectrometer. The following internal 
reference was used (CDCl3 at δ 77.0). All 13C NMR spectra were 
determined with complete proton decoupling. High-resolution 
mass spectra (HRMS) were determined with JEOL JMS-GCmate 
II and JEOL JMS-AX505HAD instruments. Column 
chromatography was performed on Silica Gel 60 PF254 (Nacalai 
Tesque) and Kanto silica gel 60 N (63–210 mesh) under pressure. 
Analytical thin layer chromatography (TLC) was carried out on 
Merck Kieselgel 60 F254 plates. Visualization was accomplished 
with UV light and phosphomolybdic acid stain solution followed 
by heating. 
 
4.2. Synthesis of (+)-tanikolide (1) 
Tetrahedron 6 
4.2.1. (S)-Methyl 3-allyloxy-4-(tert-
butyldimethylsilyloxy)butanoate (15)15j 
Allyl bromide (3.3 ml, 37.7 mmol), Ag2O (4.36 g, 18.8 mmol), 
and CaSO4 (3.42 g, 25.1 mmol) were added to a solution of (S)-
methyl 4-(tert-butylsilyloxy)-3-hydroxybutanoate (14)23 (2.34 g, 
9.42 mmol) and MS4A (2.34 g) in toluene (38 ml) at room 
temperature under N2 in the dark. After stirring for 1 day, Ag2O 
(4.36 g, 18.8 mmol) and CaSO4 (3.42 g, 25.1 mmol) were added 
again to the reaction mixture and the mixture was stirred for 1 
day. After further addition of Ag2O (4.36 g, 18.8 mmol) and 
CaSO4 (3.42 g, 25.1 mmol), the mixture was stirring for one more 
day. The reaction mixture was filtered through the pad of Celite. 
The filtrate was concentrated in vacuo, and the residue was 
purified by column chromatography (silica gel, 4% EtOAc in 
hexane) to provide 15 (2.13 g, 78%) as a colorless oil: [a]D24 –
22.9 (c 1.0, CHCl3); IR (neat, cm–1) ν 2954, 2930, 2886, 2858, 
1742, 1084, 1006, 838, 778, 669; 1H NMR (400 MHz, CDCl3) δ 
5.88 (ddt, J = 17.0, 10.4, 6.0 Hz, 1H) , 5.25 (dd, J = 17.0, 1.4 Hz, 
1H), 5.15 (dd, J = 10.4, 1.4 Hz, 1H), 4.15–4.04 (m, 2H) , 3.72 
(dd, J = 10.6, 8.0 Hz, 1H), 3.69 (s, 3H), 3.55 (dd, J = 10.6, 5.4 Hz, 
1H), 2.61 (dd, J = 15.6, 5.4 Hz, 1H), 2.49 (dd, J = 15.6, 8.0 Hz, 
1H), 0.89 (s, 9H), 0.06 (s, 6H); 13C NMR (100 MHz, CDCl3) δ 
172.2, 135.0, 116.8, 76.4, 71.5, 64.7, 51.6, 37.3, 25.9, 18.3, –5.4. 
4.2.2. (S)-3-Allyloxy-4-(tert-butyldimethylsilyloxy)butanal (16)26 
DIBAL-H (1.0 M in hexane, 12.7 mL, 12.7 mmol) was added 
dropwise to a solution of methyl ester 15 (3.05 g, 10.6 mmol) in 
CH2Cl2 (106 mL) at –78 °C under N2. After stirring at –78 °C for 
30 min, the reaction was quenched by the addition of MeOH (25 
mL) and saturated aqueous NH4Cl (12.7 mL) and then allowed to 
warm to room temperature. The mixture was dried over 
anhydrous Na2SO4 and filtered through a pad of Celite. The 
filtrate was concentrated in vacuo and the residue was purified by 
column chromatography (silica gel, 5% EtOAc in hexane) to 
provide 16 (2.59 g, 95%) as a colorless oil: [a]D24 –25.3 (c 1.0, 
CHCl3); IR (neat, cm–1) ν 2954, 2929, 2857, 1730, 1255, 1094, 
838, 778; 1H NMR (400 MHz, CDCl3) δ 9.81 (t, J = 2.4 Hz, 1H), 
5.89 (ddt, J = 17.0, 10.4, 5.6 Hz, 1H), 5.27 (ddd, J = 17.0, 3.2, 
1.4 Hz, 1H), 5.17 (ddd, J = 10.4, 3.2, 1.4 Hz, 1H), 4.13 (ddt, J = 
12.7, 5.6, 1.4 Hz, 1H), 4.06 (ddt, J = 12.7, 5.6, 1.4 Hz, 1H), 3.93 
(quint, J = 5.8 Hz, 1H), 3.74 (dd, J = 10.4, 5.0 Hz, 1H), 3.59 (dd, 
J = 10.4, 6.2 Hz, 1H), 2.64–2.62 (m, 2H), 0.89 (s, 9H), 0.06 (s, 
6H); 13C NMR (100 MHz, CDCl3) δ 201.1, 134.7, 117.1, 74.9, 
71.1, 64.6, 46.3, 25.8, 18.3, –5.5. 
4.2.3. (S)-Methyl 5-allyloxy-6-tert-butyldimethylsilyloxy-3-
oxohexanoate (17) 
A solution of the methyl diazoacetate (329 mg, 3.29 mmol) in 
CH2Cl2 (9 mL) and a solution of aldehyde 16 (567 mg, 2.19 
mmol) in CH2Cl2 (15 mL) were added to a suspension of SnCl2 
(83 mg, 0.44 mmol) in CH2Cl2 (10 mL) over 20 min at room 
temperature under N2. After stirring for 5.5 h, the reaction 
mixture was evaporated and the residue was purified by column 
chromatography (silica gel, 7% EtOAc in hexane) to provide 17 
(501 mg, 69%) as a pale yellow oil: [a]D25 –24.8 (c 1.0, CHCl3); 
IR (neat, cm–1) ν 2954, 2929, 2885, 2858, 1751, 1720, 1322, 
1255, 1117, 838, 778; 1H NMR (400 MHz, CDCl3) δ 5.87 (ddt, J 
= 22.6, 10.6, 5.6 Hz, 1H), 5.24 (dd, J = 17.8, 1.4 Hz, 1H), 5.15 
(dd, J = 10.6, 1.0 Hz, 1H) 4.11 (dd, J = 12.6, 5.6 Hz, 1H), 4.03 
(dd, J = 12.6, 5.6 Hz, 1H), 3.88 (quint, J = 6.0 Hz, 1H), 3.74 (s, 
3H), 3.68 (dd, J = 10.4, 4.8 Hz, 1H), 3.55 (dd, J = 10.4, 6.0 Hz, 
1H), 3.52 (s, 2H), 2.75 (dd, J = 6.0, 1.3 Hz, 2H), 0.89 (s, 9H), 
0.06 (s, 6H); 13C NMR (100 MHz, CDCl3) δ 201.4, 167.5, 134.8, 
117.0, 75.8, 71.4, 64.5, 52.3, 50.1, 45.4, 25.9, 18.3, –5.5; HRMS 
(EI) m/z calcd for C16H30O5Si (M)+ 330.1863, found 330.1854. 
4.2.4. (S)-Methyl 5-allyloxy-6-tert-butyldimethylsilyloxy-2-diazo-
3-oxohexanoate (5a) 
A solution of p-ABSA (1.88 g, 7.84 mmol) in CH3CN (12 
mL) and Et3N (1.8 ml, 13.1 mmol) was added dropwise to a 
solution of β-keto ester 17 (2.16 g, 6.53 mmol) in CH3CN (70 
mL) at 0 °C under N2. After stirring at room temperature for 5.5 h, 
the reaction mixture was evaporated. The residue was dissolved 
in ether (80 mL), and washed with 10% aqueous KOH (2 x 30 
mL) water (20 mL) and brine (20 mL), and dried over anhydrous 
MgSO4. The filtrate was concentrated in vacuo, and the residue 
was purified by column chromatography (silica gel, 7% EtOAc in 
hexane) to provide 5a (2.22 g, 95%) as a yellow oil: [a]D24 –13.1 
(c 1.0, CHCl3); IR (neat, cm–1) ν 2955, 2929, 2857, 2135, 1726, 
1658, 1438, 1314, 1255, 1200, 1123, 838, 778; 1H NMR (400 
MHz, CDCl3) δ 5.89 (ddd, J = 22.6, 10.8, 5.6 Hz, 1H), 5.24 (dd, 
J = 17.4, 1.4 Hz, 1H), 5.13 (br d, J = 10.8 Hz, 1H), 4.99 (m, 1H), 
4.16–4.06 (m, 2H), 3.83 (s, 3H), 3.71 (dd, J = 10.4, 5.6 Hz, 1H), 
3.17 (dd, J = 16.4, 8.0 Hz, 1H), 3.01 (dd, J = 16.4, 4.6 Hz, 1H), 
0.89 (s, 9H), 0.06 (s, 6H); 13C NMR (100 MHz, CDCl3) δ 190.5, 
161.7, 135.2, 116.6, 75.8, 71.5, 65.1, 52.2, 42.6, 25.8, 18.3, –5.4; 
HRMS (EI) m/z calcd for C16H28N2O5Si (M)+ 356.1768, found 
356.1793. 
4.2.5. (2R,5S)-Methyl 2-allyl-5-(tert-
butyldimethylsilyloxy)methyl-3-oxotetrahydrofuran-2-
carboxylate (6a) 
A solution of diazoketoester 5a (1.27 g, 3.56 mmol) in CH2Cl2 
(17 mL) was added dropwise to a solution of Rh2(OAc)4 (47 mg, 
0.11 mmol, 3 mol%) in CH2Cl2 (100 mL) at room temperature 
under N2. After refluxing for 5 h, the reaction mixture was 
evaporated and the residue was purified by column 
chromatography (silica gel, 10% EtOAc in hexane) to provide 6a 
(1.08 g, 93%) as a colorless oil: [a]D24 +5.5 (c 1.0, CHCl3); IR 
(neat, cm–1) ν 2954, 2929, 2858, 1769, 1748, 1435, 1174, 1109, 
838, 779; 1H NMR (400 MHz, CDCl3) δ 5.74 (ddt, J = 16.9, 10.1, 
7.3 Hz, 1H), 5.20–5.13 (m, 2H), 4.47 (m, 1H), 3.87 (dd, J = 10.8, 
4.6 Hz, 1H), 3.80 (dd, J = 10.8, 3.6 Hz, 1H), 3.75 (s, 3H), 2.71 
(ddt, J = 13.8, 7.3, 0.9 Hz, 1H), 2.65 (dd, J = 18.1, 6.4 Hz, 1H), 
2.60 (ddt, J = 13.8, 7.3, 0.9 Hz, 1H), 2.56 (dd, J = 18.1, 7.3 Hz, 
1H), 0.88 (s, 9H), 0.06 (s, 6H); 13C NMR (100 MHz, CDCl3) δ 
208.9, 168.2, 130.8, 120.3, 86.4, 76.1, 65.4, 52.8, 39.7, 38.5, 25.8, 
18.3, –5.5, –5.6; HRMS (EI) m/z calcd for C16H28O5Si (M)+ 
328.1706, found 328.1705. 
4.2.6. (2R,5S)-Methyl 5-(tert-butyldimethylsilyloxy)methyl-3-(4-
toluenesulfonyl)hydrazinylidene-2-allyltetrahydrofuran-2-
carboxylate (20a) 
Tosylhydrazine (109 mg, 0.58 mmol) was added to a solution 
of ketone 6a (174 mg, 0.53 mmol) in THF (0.9 mL) at room 
temperature under N2. After stirring at room temperature for 24 h, 
solvent was removed in vacuo and the residue was purified by 
column chromatography (silica gel, 20% EtOAc in hexane) to 
provide 20a (242 mg, 92%) as a colorless oil: [a]D19 –4.4 (c 1.0, 
CHCl3); IR (neat, cm–1) ν 3209, 2953, 2928, 1745, 1435, 1411, 
1347, 1254, 1169, 923, 838, 778; 1H NMR (400 MHz, CDCl3) 
δ 7.83 (dt, J = 8.7, 1.8 Hz, 2H), 7.33 (s, 2H), 7.31 (s, 1H), 5.57 
(ddt, J = 17.2, 10.1, 6.9 Hz, 1H),  4.98 (dt, J = 10.1, 1.4 Hz, 1H), 
4.91 (ddd, J = 17.2, 3.2, 1.4 Hz, 1H), 4.30 (ddd, J = 6.9, 6.8, 4.6 
Hz, 1H), 3.77 (dd, J = 10.3, 4.6 Hz, 1H), 3.611 (s, 3H), 3.609 (dd, 
J = 10.3, 6.9 Hz, 1H), 2.75 (dd, J = 14.2, 6.9 Hz, 1H), 2.60–2.53 
(m, 2H), 2.46 (dd, J = 17.4, 6.9 Hz, 1H), 2.43 (s, 3H), 0.84 (s, 
9H), 0.02 (s, 3H), 0.01 (s, 3H); 13C NMR (100 MHz, CDCl3) 
δ 159.7, 144.3, 135.1, 131.4, 129.5, 128.1, 119.7, 86.2, 78.7, 77.2, 
64.9, 52.6, 40.6, 30.2, 25.8, 21.6, 18.2, –5.4, –5.5; HRMS (EI) 
m/z calcd for C23H36N2O6SiS (M)+ 496.2063, found 496.2083. 
4.2.7. (2R,5S)-Methyl 5-(tert-butyldimethylsilyloxy)methyl-2,5-
dihydro-2-allylfuran-2-carboxylate (21a) 
Sodium cyanoborohydride (30 mg, 0.48 mmol) and 
TsOH⋅H2O (7 mg, 0.04 mmol) were added to a solution of 
tosylhydrazone 20a (60 mg, 0.12 mmol) in DMF (2.4 mL) at 
room temperature. After refluxing for 8 h, the reaction mixture 
was diluted with EtOAc (30 mL) and washed with water (20 mL) 
and brine (20 mL), and dried over anhydrous MgSO4. The filtrate 
was concentrated in vacuo, and the residue was purified by 
column chromatography (silica gel, 3% EtOAc in hexane) to 
provide 21a (14 mg, 40%) as a colorless oil: [a]D25 –79.9 (c 1.0, 
CHCl3); IR (neat, cm–1) ν 2953, 2929, 2857, 1759, 1735, 1256, 
1128, 1097, 1074, 917, 838, 778; 1H NMR (400 MHz, CDCl3) δ 
6.03 (dd, J = 6.0, 1.4 Hz, 1H), 5.88 (dd, J = 6.0, 2.3 Hz, 1H), 
5.75 (m, 1H), 5.13–5.07 (m, 2H), 4.87 (ddd, J = 6.9, 5.0, 2.5 Hz, 
1H), 3.83 (dd, J = 9.8, 5.0 Hz, 1H), 3.72 (s, 3H), 3.55 (dd, J = 9.8, 
6.9 Hz, 1H), 2.65 (ddt, J = 14.1, 7.3, 1.4 Hz, 1H), 2.54 (ddt, J = 
14.1, 7.3, 1.4 Hz, 1H), 0.88 (s, 9H), 0.05 (s, 3H), 0.04 (s, 3H); 
13C NMR (100 MHz, CDCl3) δ 172.7, 132.0, 130.7, 129.1, 118.8, 
93.2, 87.9, 65.9, 52.2, 42.4, 25.8, 18.3, –5.4, –5.5; HRMS (FAB) 
m/z calcd for C16H29O4Si (M+H)+ 313.1835, found 313.1840. 
4.2.8. (2R,5S)-Methyl 5-(tert-butyldimethylsilyloxy)methyl-2-(2-
undecen-1-yl)-3-oxotetrahydrofuran-2-carboxylate (23) 
Grubbs 2nd catalyst (4.7 mg, 0.006 mmol, 1 mol%) was added 
to the solution of 6a (181 mg, 0.55 mmol) and 1-decene (1.0 mL, 
5.51 mmol) in CHCl3 (5.5 ml) at room temperature under N2. 
After refluxing for 3 h, Grubbs 2nd catalyst (4.7 mg, 0.006 mmol, 
1 mol%) was added again to the reaction mixture and the mixture 
was refluxed for 3.5 h. Solvent was removed in vacuo, and the 
residue was purified by column chromatography (silica gel, 5% 
EtOAc in hexane) to provide 23 (214 mg, 88%) as a pale yellow 
oil: [a]D24 +11.3 (c 1.0, CHCl3); IR (neat, cm–1) ν 2954, 2927, 
2856, 1769, 1748, 1254, 1112, 838, 779; 1H NMR (400 MHz, 
CDCl3) δ 5.56 (dt, J = 14.7, 7.1 Hz, 1H), 5.37 (dt, J = 15.1, 7.6 
Hz, 1H), 4.45 (ddt, J = 7.1, 4.8, 4.0 Hz, 1H), 3.86 (dd, J = 10.6, 
4.8 Hz, 1H), 3.79 (dd, J = 10.6, 4.0 Hz, 1H), 3.74 (s, 0.4H), 3.73 
(s, 2.6H), 2.72–2.49 (m, 4H), 2.03 (dt, J = 15.6 Hz, 7.1 Hz, 0.2H), 
1.97 (dt, J = 13.6, 6.7 Hz, 0.8H), 1.31 (br s, 2H), 1.29 (br s, 2H) 
1.25 (br s, 8H), 0.88 (br s, 12H), 0.06 (s, 6H); 13C NMR (100 
MHz, CDCl3) δ 209.1, 168.4, 136.8, 135.3, 121.7, 120.9, 86.7, 
86.5, 76.1, 76.0, 65.4, 52.7, 38.9, 38.6, 32.6, 31.9, 29.50, 29.46, 
29.4, 29.3, 29.1, 27.4, 25,8, 22.6, 18.3, 14.1, –5.5.; HRMS (EI) 
m/z calcd for C24H44O5Si (M)+ 440.2958, found 440.2954. 
 4.2.9. (2R,5S)-Methyl 5-(tert-butyldimethylsilyloxy)methyl-3-(4-
toluenesulfonyl)hydrazinylidene-2-(2-undecen-1-
yl)tetrahydrofuran-2-carboxylate (20b) 
Tosylhydrazine (212 mg, 1.14 mmol) was added to a solution 
of ketone 23 (313 mg, 0.71 mmol) in THF (1.1 mL) at room 
temperature under N2. After stirring at room temperature for 24 h, 
solvent was removed in vacuo and the residue was purified by 
column chromatography (silica gel, 15% EtOAc in hexane) to 
provide 20b (424 mg, 98%) as a colorless oil: [a]D26 +18.2 (c 1.0, 
CHCl3); IR (neat, cm–1) ν 3209, 2954, 2926, 2855, 1747, 1599, 
1463, 1435, 1409, 1349, 1254, 1170, 1094, 838, 779; 1H NMR 
(400 MHz, CDCl3) δ 7.84 (d, J = 8.2 Hz, 1.6H), 7.82 (d, J = 8.2 
Hz, 0.4H), 7.47 (s, 0.2H), 7.45 (s, 0.8H), 7.31 (d, J = 8.2 Hz, 1.6 
H), 7.30 (d, J = 8.2 Hz, 0.4H), 5.44 (m, 0.2H), 5.28 (dt, J = 15.4, 
6.4 Hz, 0.8H), 5.13 (dt, J = 15.4, 7.1 Hz, 1H), 4.27 (dt, J = 11.4, 
6.9 Hz, 1H), 3.76 (dd, J = 10.5, 4.6 Hz, 1H), 3.60 (s, 3H), 3.59 
(m, 1H), 2.77–2.38 (m, 4H), 2.43 (s, 3H), 1.97 (br d, J = 6.4 Hz, 
0.4H), 1.84 (br d, J = 6.4 Hz, 1.6H), 1.26 (br s, 12H), 0.88 (t, J = 
7.1 Hz, 3H), 0.83 (s, 9H), 0.01 (s, 6H); 13C NMR (100 MHz, 
CDCl3) δ 170.3, 160.0, 144.2, 136.2, 135.2, 129.5, 128.1, 122.3, 
86.6, 78.7, 65.0, 52.5, 39.6, 32.7, 31.9, 29.6, 29.5, 29.32, 29.30, 
29.2, 25.8, 22.7, 21.6, 18.2, 14.1, –5.5; HRMS (EI) m/z calcd for 
C31H52N2O6SSi (M)+ 608.3315, found 608.3326. 
4.2.10. (2R,5S)-Methyl 5-(tert-butyldimethylsilyloxy)methyl-2,5-
dihydro-2-(2-undecen-1-yl)furan-2-carboxylate (21b) 
Sodium cyanoborohydride (270 mg, 4.30 mmol) was added to 
a solution of tosylhydrazone 20b (654 mg, 1.07 mmol) in DMF 
(54 mL) at room temperature. After refluxing for 1 h, the reaction 
mixture was diluted with EtOAc (150 mL) and washed with 
water (50 mL) and brine (50 mL), and dried over anhydrous 
Na2SO4. The filtrate was concentrated in vacuo, and the residue 
was purified by column chromatography (silica gel, 4% EtOAc in 
hexane) to provide 21b (345 mg, 76%) as a colorless oil: [a]D26 –
44.0 (c 1.0, CHCl3); IR (neat, cm–1) ν 2954, 2926, 2856, 1759, 
1735, 1255, 1095, 837, 778; 1H NMR (400 MHz, CDCl3) δ 6.00 
(d, J = 6.0, 1.2 Hz, 1H), 5.87 (dd, J = 6.0, 1.6 Hz, 1H), 5.28 (dt, J 
= 15.6, 6.8 Hz, 1H), 5.34 (dt, J = 15.6, 7.2 Hz, 1H), 4.85 (m, 1H), 
3.83 (dd, J = 10.0, 4.4 Hz, 1H), 3.72 (s, 0.1H), 3.70 (s, 2.9H), 
3.53 (dd, J = 9.6, 6.8 Hz, 1H), 2.65 (dd, J = 14.6, 6.8 Hz, 0.1H), 
2.55 (dd, J = 14.0, 7.2 Hz, 0.9H), 2.47 (dd, J = 14.0, 7.2 Hz, 
0.8H), 2.01 (dd, J = 14.0, 6.8 Hz, 0.2H), 1.96 (dd, J = 14.0, 6.8 
Hz, 1.8H), 1.25 (br s, 12H), 0.88 (t, J = 7.1 Hz, 3H), 0.88 (s, 9H), 
0.05 (s, 6H); 13C NMR (100 MHz, CDCl3) δ 172.8, 135.2, 130.6, 
130.4, 129.32, 129.26, 122.9, 93.6, 87.8, 65.9, 52.1, 41.4, 32.6, 
31.9, 29.5, 29.4, 29.32, 29.28, 29.1, 25.9, 22.7, 18.3, 14.1, –5.4; 
HRMS (EI) m/z calcd for C24H44O4Si (M)+ 424.3009, found 
424.3044. 
4.2.11. (2R,5S)-Methyl 5-(tert-butyldimethylsilyloxy)methyl-2-
undecanyltetrahydrofuran-2-carboxylate (24) 
Pd/C (20 mg, 10 wt% of 21b) was added to the solution of 
21b (204 mg, 0.48 mmol) in MeOH (2.4 mL) at room 
temperature. The reaction mixture was placed in an autoclave and 
was vigorously stirred under 10 atm of hydrogen for 2 h. The 
mixture was filtered through a pad of Celite. The filtrate was 
concentrated in vacuo and the residue was purified by column 
chromatography (silica gel, 4% EtOAc in hexane) to provide 24 
(193 mg, 94%) as a colorless oil: [a]D24 –9.3 (c 1.0, CHCl3); IR 
(neat, cm–1) ν 2926, 2855, 1735, 1463, 1254, 1128, 1090, 838, 
778; 1H NMR (400 MHz, CDCl3) δ: 4.12 (tt, J = 6.4, 4.6 Hz, 1H), 
3.78 (dd, J = 10.1, 4.6 Hz, 1H), 3.71 (s, 3H), 3.55 (dd, J = 10.1, 
6.8 Hz, 1H), 2.35 (dt, J = 6.8, 4.1 Hz, 1H), 2.01 (m, 1H), 1.88–
1.66 (m, 4H), 1.24 (br s, 12H), 0.88 (br s, 12H), 0.05 (s, 6H); 13C 
NMR (100 MHz, CDCl3) δ 175.3, 87.1, 81.0, 65.8, 52.0, 38.6, 
35.0, 31.9, 29.8, 29.6, 29.5, 29.4, 29.3, 28.5, 25.9, 24.3, 22.7, 
18.3, 14.1, –5.4; HRMS (EI) m/z calcd for C24H48O4Si (M)+ 
428.3322, found 428.3362. 
4.2.12. (2R,5S)-5-(tert-butyldimethylsilyloxy)methyl-2-
undecanyltetrahydrofuran-2-methanol (25) 
DIBAL-H (1.0 M in hexane, 1.1 mL 1.13 mmol) was added 
dropwise to a solution of methyl ester 24 (193 mg, 0.45 mmol) in 
CH2Cl2 (4.5 mL) at –78 °C under N2. After stirring at 0 °C for 15 
min, the reaction mixture was quenched by the addition of 
MeOH (2.2 mL) and saturated aqueous NH4Cl (1.1 mL) and then 
allowed to warm to room temperature. The mixture was dried 
over anhydrous Na2SO4 and filtered through a pad of Celite. The 
filtrate was concentrated in vacuo and the residue was purified by 
column chromatography (silica gel, 6% EtOAc in hexane) to 
provide 25 (161 mg, 89%) as a colorless oil: [a]D24 –10.9 (c 1.0, 
CHCl3); IR (neat, cm–1) ν 3471, 2953, 2926, 2855, 1464, 1255, 
1090, 837, 777; 1H NMR (CDCl3) δ: 4.11 (br t, J = 7.2 Hz, 1H), 
3.89 (dd, J = 10.8, 3.2 Hz, 1H), 3.57 (dt, J = 10.8, 2.8 Hz, 1H), 
3.40 (t, J = 10.8 Hz, 2H), 3.08 (dd, J = 10.8, 2.8 Hz, 1H), 2.17–
2.00 (m, 2H), 1.91–1.75 (m, 2H), 1.47 (br t, J = 4.0 Hz, 2H), 1.25 
(br s, 18H), 0.92 (s, 9H), 0.88 (t, J = 6.8 Hz, 3H), 0.09 (s, 6H); 
13C NMR (100 MHz, CDCl3) δ 86.5, 79.8, 69.3, 64.8, 37.9, 32.5, 
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31.9, 30.3, 29.64, 29.59, 29.58, 29.3, 28.0, 25.9, 24.0, 22.7, 18.5, 
14.1, –5.5; HRMS (EI) m/z calcd for C23H48O3Si (M)+ 400.3373, 
found 400.3384. 
4.2.13. (2R,5S)-5-(tert-Butyldimethylsilyloxy)methyl-2-
(methoxymethyloxy)methyl-2-undecanyltetrahydrofuran (26) 
iPr2NEt (0.2 mL, 2.60 mmol) and MOMCl (0.75 mL, 4.33 
mmol) was added to the solution of 25 (347 mg, 0.87 mmol) in 
CH2Cl2 (4.3 mL) at 0 °C under N2. After stirring at 0 °C for 30 
min, the reaction mixture was allowed to warm to room 
temperature and was stirred for 5.5 h. The mixture was quenched 
by the addition of saturated aqueous NaHCO3 and the mixture 
was extracted with EtOAc (3 x 10 mL). Combined organic layers 
were washed with water (10 mL) and brine (10 mL) and dried 
over anhydrous MgSO4. The filtrate was concentrated in vacuo, 
and the residue was purified by column chromatography (silica 
gel, 6% EtOAc in hexane) to provide 26 (372 mg, 97%) as a 
colorless oil: [a]D24 –6.5 (c 1.0, CHCl3); IR (neat, cm–1) ν 2926, 
2855, 1463, 1254, 1149, 1112, 1053, 837, 776; 1H NMR (400 
MHz, CDCl3) δ 4.63 (s, 2H), 4.03 (dt, J = 10.4, 6.2 Hz, 1H), 3.65 
(dd, J = 10.4, 4.2 Hz, 1H), 3.53 (dd, J = 10.4, 6.0 Hz, 1H), 3.41 
(d, J = 10.0 Hz, 1H), 3.37 (d, J = 10.0 Hz, 1H), 3.36 (s, 3H), 
1.99–1.70 (m, 4H), 1.55 (dd, J = 9.4, 5.6 Hz, 2H), 1.26 (br s, 
18H), 0.89 (br s, 12H), 0.05 (s, 6H); 13C NMR (100 MHz, 
CDCl3) δ 96.8, 84.8, 79.9, 72.6, 65.9, 55.2, 37.1, 32.5, 31.9, 30.3, 
29.7, 29.6, 29.3, 28.4, 25.9, 24.1, 22.7, 18.4, 14.1; HRMS (EI) 
m/z calcd for C25H52O4Si (M)+ 444.3635, found 444.3658. 
4.2.14. (2R,5S)-2-(Methoxymethyloxy)methyl-2-
undecanyltetrahydrofuran-5-methanol (27) 
TBAF (1.0 M in THF, 0.21 mL, 0.21 mmol) was added to a 
solution of 26 (85 mg, 0.19 mmol) in THF (1.9 mL) at 0 °C 
under N2 and then the resulting mixture was stirred at room 
temperature. After stirring for 2.5 h, the reaction mixture was 
diluted with EtOAc (20 mL) and washed with water (10 mL) and 
brine (10 mL), and dried over anhydrous Na2SO4. The filtrate 
was concentrated in vacuo, and the residue was purified by 
column chromatography (silica gel, 25% EtOAc in hexane) to 
provide 27 (63 mg, 100%) as a colorless oil: [a]D24 +0.66 (c 1.0, 
CHCl3); IR (neat, cm–1) ν 3447, 2925, 2854, 1465, 1150, 1112, 
1048; 1H NMR (400 MHz, CDCl3) δ 4.67 (d, J = 8.4 Hz, 1H), 
4.66 (d, J = 8.4 Hz, 1H), 4.17 (ddd, J = 9.6, 6.8, 3.2 Hz, 1H), 
3.79 (dt, J = 11.6, 3.2 Hz, 1H), 3.54 (d, J = 10.0 Hz, 1H), 3.45 (m, 
1H), 3.45 (d, J = 10.0 Hz, 1H), 3.38 (s, 3H), 2.94 (dd, J = 8.6, 3.2 
Hz, 1H), 2.06–1.93 (m, 3H), 1.76 (m, 1H), 1.56–1.49 (m, 2H), 
1.28 (br s, 4H), 1.26 (br s, 14H), 0.88 (t, J = 7.2 Hz, 3H); 13C 
NMR (100 MHz, CDCl3) δ 96.6, 85.2, 80.1, 72.8, 65.1, 55.4, 
37.9, 32.6, 31.9, 30.2, 29.64, 29.60, 29.58, 29.5, 29.33, 29.31, 
27.6, 24.0, 22.7, 14.1; HRMS (EI) m/z calcd for C19H38O4 (M)+ 
330.2770, found 330.2779. 
4.2.15. (2R,5S)-2-(Methoxymethyloxy)methyl-2-
undecanyltetrahydrofuran-5-carboaldehyde (28) 
A solution of DMSO (0.044 mL, 0.56 mmol) in CH2Cl2 (0.24 
mL) was dropped to a solution of oxalyl chloride (0.032 mL, 0.38 
mmol) in CH2Cl2 (0.4 mL) at –78 °C under N2 over 15 min. A 
solution of alcohol 27 (62 mg, 0.19 mmol) in CH2Cl2 (0.3 mL) 
was then dropped to the reaction mixture over 15 min. After 
stirring for 30 min at –78 °C, triethylamine (0.13 mL, 0.94 
mmol) was added to the reaction mixture and the mixture was 
allowed to warm to room temperature over 80 min. After stirred 
at room temperature for 40 min, the reaction mixture was 
quenched by the addition of saturated aqueous NH4Cl (1 mL). 
The mixture was extracted with CH2Cl2 (3 x 10 mL) and 
combined organic layers were dried over anhydrous Na2SO4. The 
filtrate was concentrated in vacuo, and the residue was purified 
by column chromatography (silica gel, 20% EtOAc in hexane to 
50% EtOAc in hexane) to provide 28 (51 mg, 82%) as a colorless 
oil: [a]D25 –22.2 (c 1.0, CHCl3); IR (neat, cm–1) ν IR (neat, cm–
1) ν 3447, 2925, 2854, 1465, 1150, 1112, 1048; 1H NMR (400 
MHz, CDCl3) δ 9.68 (d, J = 1.6 Hz, 1H), 4.64 (s, 2H), 4.30 (t, J = 
10.8 Hz, 1H), 3.51 (d, J = 10.0 Hz, 1H) , 3.46 (d, J = 10.0 Hz, 
1H), 3.36 (s, 3H), 2.18–2.10 (m, 2H), 1.93 (dt, J = 12.0, 6.8 Hz, 
1H), 1.79 (dt, J = 12.0, 8.0 Hz, 1H), 1.60 (br s, 2H), 1.26 (br s, 
18H), 0.88 (t, J = 6.6 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 
203.8, 96.7, 87.1, 83.7, 72.7, 55.4, 37.3, 32.2, 31.9, 30.2, 29.63, 
29.60, 29.57, 29.3, 28.0, 24.0, 22.7, 14.1; HRMS (EI) m/z calcd 
for C19H38O4 (M)+ 328.2614, found 328.2616. 
4.2.16. (S)-5-(Methoxymethyloxy)methyl-5-
undecanyltetrahydropyran-1-one (30) 
1,3-Bis(2,6-diisopropylphenyl)imidazolinium chloride (29) 
(20 mg, 0.05 mmol, 30 mol%) and DBU (0.005 mL, 0.031 mmol, 
20 mol%) was added to the solution of aldehyde 28 (51 mg, 0.16 
mmol) in CHCl3 (3.1 mL) at room temperature under N2. After 
refluxing for 24 h, the reaction mixture was quenched by the 
addition of saturated aqueous NH4Cl (3 mL) at room temperature. 
The mixture was extracted with CH2Cl2 (3 x 10 mL) and 
combined organic layers were dried over anhydrous Na2SO4. The 
filtrate was concentrated in vacuo, and the residue was purified 
by column chromatography (silica gel, 20% EtOAc in hexane) to 
provide 30 (36 mg, 71%) as a colorless oil: [a]D27 –2.8 (c 1.0, 
CHCl3); IR (neat, cm–1) ν 2925, 2854, 1738, 1465, 1330, 1248, 
1150, 1114, 1050, 921; 1H NMR (400 MHz, CDCl3) δ 4.63 (s, 
2H), 3.56 (d, J = 10.0 Hz, 1H) , 3.51 (d, J = 10.0 Hz, 1H), 3.36 (s, 
3H), 2.50 (dt, J = 18.0, 6.8 Hz, 1H), 2.44 (dt, J = 18.0, 6.8 Hz, 
1H), 1.98 (dt, J = 12.4, 4.4 Hz, 1H), 1.92 (dt, J = 10.4, 3.6 Hz, 
1H), 1.85–1.60 (m, 4H), 1.26 (br s, 18H), 0.88 (t, J = 7.2 Hz, 
3H); 13C NMR (100 MHz, CDCl3) δ 171.5, 96.7, 84.6, 71.8, 55.4, 
38.0, 31.9, 29.9, 29.8, 29.6, 29.59, 29.58, 29.52, 29.46, 29.3, 27.7, 
23.0, 22.7, 16.8, 14.1; HRMS (EI) m/z calcd for C19H38O4 (M)+ 
328.2614, found 328.2648. 
4.2.17. (+)-Tanikolide (1) 
Aqueous HCl (4 M, 1.8 mL) was added dropwise to the 
solution of MOM ether 30 (120 mg, 0.37 mmol) in THF (1.8 mL) 
at room temperature. After stirring the reaction mixture at 50 °C 
for 6 h, the reaction mixture was saturated with NaCl. The 
mixture was extracted with CHCl3 (3 x 20 mL) and combined 
organic layers were dried over anhydrous Na2SO4. The filtrate 
was concentrated in vacuo, and the residue was purified by 
column chromatography (silica gel, 40% EtOAc in hexane) to 
provide 1 (59 mg, 56%) as a white solid: mp 39–40 °C (lit.6h 
39−41 °C); [a]D24 +2.2 (c 0.65, CHCl3) (lit.1 [a]D25 +2.3 (c 0.65, 
CHCl3)); IR (neat, cm–1) ν 3395, 2923, 2851, 1701, 1468, 1265, 
1051; 1H NMR (400 MHz, CDCl3) δ 3.67 (d, J = 12.0 Hz, 1H) , 
3.54 (d, J = 12.0 Hz, 1H), 2.94 (br s, 1H), 2.47 (t, J = 6.6 Hz, 1H), 
1.97–1.80 (m, 3H), 1.75–1.61 (m, 3H), 1.26 (br s, 18H), 0.88 (t, J 
= 6.8 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 172.0, 86.6, 67.3, 
36.7, 31.8, 29.9, 29.7, 29.53, 29.51, 29.47, 29.3, 29.2. 26.6, 23.3, 
22.6, 16.6, 14.0. 
4.3. Synthesis of (4S)- and (4R)-hydroxytanikolides (2) 
4.3.1. (2R,3S,5S)- and (2R,3R,5S)-2-allyl-5-(tert-
butyldimethylsilyloxy)methyl-3-hydroxytetrahydrofuran-2-
methanol {(3S)-8a} and {(3R)-8a} 
LiAlH4 (229 mg, 6.02 mmol) was added to a solution of 3-
oxotetrahydrofuran 6a (989 mg, 3.01 mmol) in THF (15 mL) at 
0 °C under N2. After stirring at 0 °C for 4.5 h, the reaction 
mixture was diluted by excess amount of Et2O and quenched by 
addition of H2O (1.1 mL) and 15% aqueous NaOH (0.3 mL) and 
stirred at room temperature for 1 h. The mixture was filtered 
through a pad of Celite. The filtrate was concentrated in vacuo 
and the residue was purified by column chromatography (silica 
gel, 25% EtOAc in hexane) to provide (3S)-8a (471 mg, 52%) as 
a colorless oil and (3R)-8a (337 mg, 37%) as a white solid. (3S)-
8a: [a]D24 +17.9 (c 1.0, CHCl3); IR (neat, cm–1) ν 3419, 3076, 
2954, 2929, 2858, 1640, 1471, 1256, 1091, 837, 778; 1H NMR 
(400 MHz, CDCl3) δ 5.83 (ddt, J = 17.6, 9.6, 7.2 Hz, 1H), 5.14 
(dd, J = 7.2, 1.2 Hz, 1H), 5.10 (br s, 1H), 4.20–4.13 (m, 2H), 3.92 
(dd, J = 11.0, 2.4 Hz, 1H), 3.70 (d, J = 11.6 Hz, 1H), 3.70 (d, J = 
6.0 Hz, 1H), 3.62 (d, J = 11.6 Hz, 1H), 3.54 (dd, J = 11.0, 2.4 Hz, 
1H), 3.08 (dd, J = 7.6, 6.0 Hz, 1H), 2.43 (dt, J = 13.2, 7.6 Hz, 
1H), 2.24 (ddt, J = 13.8, 7.6, 1.2 Hz, 2H), 2.03 (ddd, J = 13.2, 6.0, 
5.6 Hz, 1H), 0.93 (s, 9H), 0.12 (s, 6H); 13C NMR (100 MHz, 
CDCl3) δ 133.1, 118.4, 86.7, 77.0, 76.4, 65.9, 65.0, 40.0, 36.7, 
25.9, 18.5, –5.51; HRMS (EI) m/z calcd for C15H30O4Si (M)+ 
302.1913, found 302.1915. (3R)-8a: mp 43–44 °C, [a]D25 –8.0 (c 
1.0, CHCl3); IR (KBr, cm–1) ν 3323, 3075, 2952, 2931, 2868, 
1641, 1464, 1254, 1097, 1033, 996, 836, 777; 1H NMR (400 
MHz, CDCl3) δ 5.90 (ddt, J = 17.4, 10.0, 7.2 Hz, 1H), 5.18 (ddd, 
J = 17.4, 3.6, 1.2 Hz, 1H), 5.13 (ddd, J = 10.0, 1.2, 0.8 Hz, 1H), 
4.40 (dd, J = 6.8, 3.6 Hz, 1H), 4.35 (ddt, J = 9.4, 6.8, 2.4 Hz, 1H), 
3.93 (dd, J = 11.2, 6.8 Hz, 1H), 3.59 (dd, J = 11.6, 3.6 Hz, 1H), 
3.57 (dd, J = 11.2, 1.6 Hz, 1H), 3.48 (dd, J = 11.6, 9.2 Hz, 1H), 
2.99 (dd, J = 9.4, 3.6 Hz, 1H), 2.45 (br d, J = 7.2 Hz, 2H), 2.44 
(m, 1H), 1.88 (ddd, J = 13.4, 7.2, 3.2 Hz, 1H), 1.82 (br d, J = 3.6 
Hz, 1H), 0.91 (s, 9H), 0.09 (s, 6H); 13C NMR (100 MHz, CDCl3) 
δ 134.5, 118.1, 87.6, 77.7, 75.3, 67.0, 64.5, 37.1, 36.4, 25.9, 18.5, 
–5.5; HRMS (EI) m/z calcd for C15H30O4Si (M)+ 302.1913, found 
302.1872. 
4.3.2. (4aS,6S,7aS)-4a-Allyl-6-(tert-butyldimethylsilyloxy)methyl-
2,2-dimethyl-4H-furo[3,2-d][1,3]dioxine {(3S)-31} 
TsOH⋅H2O (22 mg, 0.11 mmol) was added to a solution of 
diol (3S)-8a (574 mg, 1.90 mmol) and 2,2-dimethoxypropane 
(2.3 mL, 19.0 mmol) in benzene (19 mL) at room temperature. 
After refluxing for 30 min, the reaction mixture was quenched by 
saturated NaHCO3 at room temperature. After stirring for 15 min 
at room tempertue, the reaction mixture was diluted with EtOAc 
(20 mL) and washed with water (20 mL) and brine (20 mL), and 
dried over anhydrous Na2SO4. The filtrate was concentrated in 
vacuo, and the residue was purified by column chromatography 
(silica gel, 5% EtOAc in hexane) to provide acetonide (3S)-31 
(622 mg, 96%) as a colorless oil: [a]D24 +17.1 (c 1.0, CHCl3); IR 
(neat, cm–1) ν 3077, 2986, 2954, 2929, 2857, 1641, 1472, 1373, 
1256, 1227, 1094, 836, 777; 1H NMR (400 MHz, CDCl3) δ 5.82 
(m, 1H), 5.13 (s, 1H), 5.10 (d, J = 8.0 Hz, 1H), 4.17 (dddd, J = 
11.6, 5.8, 5.2, 1.2 Hz, 1H), 4.07 (d, J = 5.6 Hz, 1H), 3.78 (dd, J = 
9.6, 1.6 Hz, 1H), 3.73 (d, J = 12.0 Hz, 1H), 3.65 (dd, J = 9.6, 8.0 
Hz, 1H), 3.63 (d, J = 12.0 Hz, 1H), 2.31–2.15 (m, 3H), 1.92 (dd, 
J = 13.6, 2.8 Hz, 1H), 1.36 (s, 3H), 1.35 (s, 3H), 0.90 (s, 9H), 
0.08 (s, 6H); 13C NMR (100 MHz, CDCl3) δ 132.7, 118.5, 98.3, 
82.1, 79.1, 74.5, 66.5, 64.9, 40.2, 34.5, 26.9, 26.0, 21.2, 18.4, –
5.2; HRMS (EI) m/z calcd for C18H35O4Si (M+H)+ 343.2305, 
found 343.2294. 
4.3.3. (4aS,6S,7aS)-4a-Allyl-2,2-dimethyl-4H-furo[3,2-
d][1,3]dioxine-6-methanol {(3S)-44} 
TBAF (1.0 M in THF, 1.0 mL, 1.00 mmol) was added to a 
solution of silyl ether (3S)-31 (312 mg, 0.91 mmol) in THF (9.0 
mL) at 0 °C under N2 and then the resulting mixture was stirred 
at room temperature. After stirring for 1.5 h, the reaction mixture 
was diluted with EtOAc (30 mL) and washed with water (15 mL) 
and brine (15 mL), and dried over anhydrous Na2SO4. The filtrate 
was concentrated in vacuo, and the residue was purified by 
column chromatography (silica gel, 45% EtOAc in hexane) to 
provide alcohol (3S)-44 (206 mg, 99%) as a colorless oil: [a]D25 
+53.8 (c 1.0, CHCl3); IR (neat, cm–1) ν 3464, 3076, 2988, 2940, 
1639, 1438, 1376, 1227, 1201, 1159, 1052, 916, 862; 1H NMR 
(400 MHz, CDCl3) δ 5.81 (m, 1H), 5.15 (d, J = 7.6 Hz, 1H), 5.14 
(dd, J = 18.0, 1.6 Hz, 1H), 4.33 (m, 1H), 4.15 (d, J = 5.6 Hz, 1H), 
3.79 (d, J = 6.8 Hz, 2H), 3.78 (m, 1H), 3.65 (m, 1H), 2.69 (t, J = 
5.0 Hz, 1H), 2.41 (dt, J = 14.4, 5.6 Hz, 1H), 2.23 (dd, J = 14.4, 
7.2 Hz, 1H), 2.15 (dd, J = 14.4, 7.6 Hz, 1H), 1.91 (dd, J = 14.4, 
3.4 Hz, 1H), 1.40 (s, 3H), 1.39 (s, 3H); 13C NMR (100 MHz, 
CDCl3) δ 132.1, 118.9, 98.3, 81.1, 78.1, 73.9, 65.2, 64.4, 39.4, 
34.0, 27.4, 20.4; HRMS (EI) m/z calcd for C12H20O4 (M)+ 
228.1362, found 228.1359. 
4.3.4. (4aS,6S,7aS)-4a-Allyl-2,2-dimethyl-4H-furo[3,2-
d][1,3]dioxine-6-carboaldehyde {(3S)-32} 
A solution of DMSO (284 mg, 3.64 mmol) in CH2Cl2 (1.3 
mL) was dropped to a solution of oxalyl chloride (369 mg, 2.91 
mmol) in CH2Cl2 (2.0 mL) at –78 °C under N2 over 15 min. A 
solution of alcohol (3S)-44 (332 mg, 1.45 mmol) in CH2Cl2 (1.5 
mL) was then dropped to the reaction mixture over 15 min. After 
stirring for 30 min at –78 °C, triethylamine (1.0 mL, 7.27 mmol) 
was added to the reaction mixture and the mixture was allowed to 
warm to room temperature over 60 min. After stirred at room 
temperature for 30 min, the reaction mixture was quenched by 
the addition of saturated aqueous NH4Cl (10 mL). The mixture 
was extracted with CH2Cl2 (3 x 15 mL) and combined organic 
layers were dried over anhydrous Na2SO4. The filtrate was 
concentrated in vacuo, and the residue was purified by column 
chromatography (silica gel, 25% EtOAc in hexane) to provide 
aldehyde (3S)-32 (290 mg, 88%) as a colorless oil: [a]D26 +37.6 
(c 1.0, CHCl3); IR (neat, cm–1) ν 2990, 2939, 2817, 1732, 1639, 
1449, 1438, 1375, 1227, 1202, 1159, 1096, 1077, 1058, 1024, 
921, 857, 821; 1H NMR (400 MHz, CDCl3) δ 9.81 (s, 1H), 5.81 
(ddt, J = 17.6, 9.6, 7.6 Hz, 1H), 5.17 (d, J = 9.6 Hz, 1H), 5.15 (d, 
J = 17.6 Hz, 1H), 4.38 (d, J = 10.0 Hz, 1H), 4.16 (d, J = 4.0 Hz, 
1H), 3.85 (s, 2H), 2.50 (ddd, J = 13.8, 9.8, 4.0 Hz, 1H), 2.28–
2.15 (m, 3H), 1.38 (s, 3H), 1.32 (s, 3H); 13C NMR (100 MHz, 
CDCl3) δ 205.1, 131.9, 119.2, 97.9, 82.4, 82.2, 72.8, 64.3, 40.8, 
37.3, 27.5, 20.5; HRMS (EI) m/z calcd for C12H18O4 (M)+ 
226.1205, found 226.1211. 
4.3.5. (4aS,8aS)-4a-Allyl-2,2-dimethyl-4H-pyrano[3,2-
d][1,3]dioxine-6-one {(4S)-33} 
Catalyst 29 (30 mg, 0.07 mmol, 30 mol%) and DBU (0.007 
mL, 0.05 mmol, 20 mol%) was added to the solution of aldehyde 
(3S)-32 (53 mg, 0.23 mmol) in CHCl3 (7.0 mL) at room 
temperature under N2. After refluxing for 10 h, the reaction 
mixture was quenched by the addition of saturated aqueous 
NH4Cl (3 mL) at room temperature. The mixture was extracted 
with CH2Cl2 (3 x 10 mL) and combined organic layers were dried 
over anhydrous Na2SO4. The filtrate was concentrated in vacuo, 
and the residue was purified by column chromatography (silica 
gel, 30% EtOAc in hexane) to provide lactone (4S)-33 (40 mg, 
75%) as a white solid: mp 85–86 °C; [a]D24 +100.3 (c 1.0, 
CHCl3); IR (KBr, cm–1) ν 3004, 2986, 2971, 2954, 2909, 1731, 
1643, 1456, 1388, 1378, 1350, 1314, 1263, 1209, 1175, 1156, 
1119, 1086, 1037, 1007, 986, 941, 863, 732; 1H NMR (400 MHz, 
CDCl3) δ 5.81 (dddd, 16.9, 9.6, 7.3, 6.6 Hz, 1H), 5.21 (d, J = 9.6 
Hz, 1H), 5.18 (dd, J = 16.9, 1.4 Hz, 1H), 4.03 (t, J = 3.2 Hz, 1H), 
3.81 (d, J = 12.6 Hz, 1H), 3.70 (d, J = 12.6 Hz, 1H), 2.76 (ddd, J 
= 18.2, 12.8, 7.3 Hz, 1H), 2.49–2.43 (m, 2H), 2.31 (dd, J = 14.4, 
8.0 Hz, 1H), 2.10 (m 1H), 1.94 (dddd, J = 14.4, 7.4, 3.2, 1.8 Hz, 
1H), 1.44 (s, 3H), 1.39 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 
170.4, 130.4, 120.3, 98.7, 79.7, 65.5, 64.9, 40.9, 27.6, 24.3, 22.2, 
20.0; HRMS (EI) m/z calcd for C12H18O4 (M)+ 226.1205, found 
226.1243. 
4.3.6. (4aS,8aS)-2,2-dimethyl-4a-(2-undecen-1-yl)-4H-
pyrano[3,2-d][1,3]dioxine-6-one {(4S)-45} 
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Grubbs 2nd catalyst (3.3 mg, 0.004 mmol) was added to the 
solution of (4S)-33 (87 mg, 0.38 mmol) and 1-decene (0.36 mL, 
1.92 mmol) in CH2Cl2 (3.8 mL) at room temperature under N2. 
After refluxing for 3 h, 1-decene (0.36 mL, 1.92 mmol) and 
Grubbs 2nd catalyst (3.3 mg, 0.004 mmol) were added to the 
reaction mixture and the mixture was refluxed for 3 h. Solvent 
was removed in vacuo, and the residue was purified by column 
chromatography (silica gel, 20% EtOAc in hexane) to provide 
(4S)-45 (119 mg, 92%) as a colorless oil: [a]D24 +59.0 (c 1.0, 
CHCl3); IR (neat, cm–1) ν 2991, 2925, 2854, 1733, 1456, 1377, 
1250, 1205, 1162, 1090, 1059, 1003, 989, 938, 864; 1H NMR 
(400 MHz, CDCl3) δ 5.56 (dt, J = 15.1, 6.9 Hz, 1H), 5.38 (ddd, J 
= 15.1, 7.8, 6.9 Hz, 1H), 4.02 (t, J = 3.2 Hz, 1H), 3.80 (d, J = 
12.8 Hz, 1H), 3.68 (d, J = 12.8 Hz, 1H), 2.75 (ddd, J = 18.1, 12.5, 
7.3 Hz, 1H), 2.45 (ddd, J = 18.1, 6.4, 1.8 Hz, 1H), 2.39 (dd, J = 
14.4, 6.4 Hz, 1H), 2.24 (dd, J = 14.4, 7.8 Hz, 1H), 2.15–2.11 (m, 
1H), 2.02 (dd, J = 14.0, 6.9 Hz, 2H), 1.92 (dddd, J = 14.5, 7.3, 
3.2, 1.8 Hz, 1H), 1.43 (s, 3H), 1.39 (s, 3H), 1.35–1.30 (m, 3H), 
1.26 (br s, 9H), 0.88 (t, J = 7.3 Hz, 3H); 13C NMR (100 MHz, 
CDCl3) δ 170.5, 136.7, 121.5, 98.6, 80.0, 65.6, 64.8, 39.7, 32.5, 
31.8, 29.4, 29.2, 29.2, 29.1, 27.7, 24.4, 22.6, 22.2, 19.9, 14.1; 
HRMS (EI) m/z calcd for C20H34O4 (M)+ 338.2457, found 
338.2420. 
4.3.7. (4aS,8aS)-2,2-dimethyl-4a-undecyl-4H-pyrano[3,2-
d][1,3]dioxine-6-one {(4S)-34} 
Pd/C {23 mg, 10 wt% of (4S)-45} was added to the solution 
of (4S)-45 (231 mg, 0.68 mmol) in MeOH (3.4 mL) at room 
temperature. The reaction mixture was vigorously stirred under 
H2 atmosphere for 1.5 h. The mixture was filtered through a pad 
of Celite. The filtrate was concentrated in vacuo and the residue 
was purified by column chromatography (silica gel, 25% EtOAc 
in hexane) to provide (4S)-34 (219 mg, 94%) as a white solid: mp 
62–63 °C; [a]D24 +55.1 (c 1.0, CHCl3); IR (KBr, cm–1) ν 3004, 
2945, 2914, 2852, 1725, 1473, 1380, 1262, 1212, 1149, 1092, 
1042, 989, 939, 863; 1H NMR (400 MHz, CDCl3) δ 3.99 (t, J = 
2.8 Hz, 1H), 3.81 (d, J = 12.8 Hz, 1H), 3.76 (d, J = 12.8 Hz, 1H), 
2.76 (ddd, J = 18.4, 12.4, 7.2 Hz, 1H), 2.45 (ddd, J = 18.4, 5.4, 
1.6 Hz, 1H), 2.09 (m, 1H), 1.93 (dddd, J = 14.6, 7.2, 3.6, 1.6 Hz, 
1H), 1.66–1.49 (m, 3H), 1.45 (s, 3H), 1.40 (s, 3H), 1.26 (br s, 
17H), 0.88 (t, J = 6.8 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 
170.7, 98.5, 80.2, 65.5, 65.5, 36.6, 31.9, 30.0, 29.5, 29.5, 29.3, 
29.3, 29.3, 27.8, 24.4, 22.7, 22.4, 22.2, 19.9, 14.1; HRMS (EI) 
m/z calcd for C20H36O4 (M)+ 340.2614, found 340.2607. 
4.3.8. (4S)-hydroxytanikolide (2) 
1 M HCl (3.2 mL) was added dropwise to the solution of 
acetonide (4S)-34 (219 mg, 0.64 mmol) in THF (3.2 mL) at room 
temperature. After stirring the reaction mixture for 24 h, the 
reaction mixture was quenched by saturated aqueous NaHCO3 (3 
mL). The mixture was extracted with Et2O (3 x 10 mL) and 
combined organic layers were dried over anhydrous Na2SO4. The 
filtrate concentrated in vacuo, and the residue was purified by 
column chromatography (silica gel, 50% EtOAc in hexane) to 
provide (4S)-hydroxytanikolide (2, 181 mg, 94%) as a white 
solid: mp 79–80 °C; [a]D20 +13.3 (c 1.0, CHCl3); IR (KBr, cm–1) 
ν 3485, 3419, 2954, 2920, 2850, 1764, 1473, 1464, 1402, 1344, 
1198, 1112, 1033, 1011, 990, 955, 821; 1H NMR (400 MHz, 
CDCl3) δ 4.53 (t, J = 7.2 Hz, 1H), 3.78 (dd, J = 11.6, 4.0 Hz, 1H), 
3.61 (dd, J = 11.6, 9.0 Hz, 1H), 2.65–2.47 (m, 3H), 2.37 (ddd, J = 
18.0, 12.4, 9.2 Hz, 1H), 2.17 (m, 1H), 2.08 (dd, J = 8.8, 4.0 Hz, 
1H), 1.51 (m, 1H), 1.44–1.39 (m, 2H), 1.26 (br s, 17H), 0.88 (t, J 
= 6.7 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 176.8, 84.3, 73.6, 
65.9, 33.3, 31.9, 30.2, 29.60, 29.58, 29.53, 29.45, 29.3, 28.3, 22.8, 
22.7, 21.9, 14.1; HRMS (EI) m/z calcd for C17H32O4 (M)+ 
300.2301, found 300.2311. 
4.3.9. (2R,3R,5S)-5-(tert-Butyldimethylsilyloxy)methyl-3- 
methoxymethyloxy-2-(methoxymethyloxy)methyl-2-
allyltetrahydrofuran {(3R)-35} 
iPr2NEt (0.1 mL, 0.58 mmol) and MOMCl (0.03 mL, 0.41 
mmol) was added to the solution of diol (3R)-8a (35 mg, 0.12 
mmol) in CH2Cl2 (0.6 mL) at 0 °C under N2. After stirring at 
0 °C for 1 h, the reaction mixture was allowed to warm to room 
temperature. After stirring the reaction mixture for 3 h, iPr2NEt 
(0.01 mL, 0.06 mmol) and MOMCl (0.004 mL, 0.06 mmol) was 
added to the solution and the reaction mixture was stirred for 3 h. 
The mixture was quenched by the addition of saturated aqueous 
NaHCO3 and the mixture was extracted with EtOAc (3 x 5 mL). 
Combined organic layers were washed with water (10 mL) and 
brine (10 mL) and dried over anhydrous Na2SO4. The filtrate was 
concentrated in vacuo, and the residue was purified by column 
chromatography (silica gel, 10% EtOAc in hexane) to provide 
(3R)-35 (38 mg, 84%) as a colorless oil: [a]D30 +6.3 (c 0.87, 
CHCl3); IR (neat, cm–1) ν 3075, 2952, 2929, 2885, 2856, 2823, 
2770, 1640, 1471, 1403, 1388, 1362, 1254, 1217, 1149, 1111, 
1043, 919, 837, 777; 1H NMR (400 MHz, CDCl3) δ 5.94 (dddd, J 
= 17.2, 9.6, 8.4, 6.4 Hz, 1H), 5.10 (d, J = 17.2 Hz, 1H), 5.07 (d, J 
= 9.6 Hz, 1H), 4.68 (d, J = 9.6 Hz, 1H), 4.66 (d, J = 9.6 Hz, 1H), 
4.61 (d, J = 6.8 Hz, 1H), 4.59 (d, J = 6.8 Hz, 1H), 4.22 (dd, J = 
6.4, 4.8 Hz, 1H), 4.18 (m, 1H), 3.60 (ddd, J = 14.4, 10.6, 4.0 Hz, 
2H), 3.46 (d, J = 10.0 Hz, 1H), 3.38 (s, 3H), 3.35 (s, 3H), 3.34 (d, 
J = 10.0 Hz, 1H), 2.50 (dd, J = 14.0, 6.4 Hz, 1H), 2.36 (dd, J = 
14.0, 8.4 Hz, 1H), 2.13 (dt, J = 13.2, 6.4 Hz, 1H), 2.02 (ddd, J = 
13.2, 7.2, 4.8 Hz, 1H), 0.89 (s, 9H), 0.05 (s, 6H); 13C NMR (100 
MHz, CDCl3) δ 134.6, 117.4, 96.8, 96.0, 85.3, 79.7, 77.5, 70.9, 
65.6, 55.5, 55.3, 36.2, 34.3, 25.9, 18.3, –5.3, –5.4; HRMS (FAB) 
m/z calcd for C19H39O6Si (M+H)+ 391.2516, found 391.2516. 
4.3.10. (2R,3R,5S)-3-Methoxymethyloxy-2-
(methoxymethyloxy)methyl-2-allyltetrahydrofuran-5-methanol 
{(3R)-46} 
TBAF (1.0 M in THF, 1.4 mL, 1.42 mmol) was added to a 
solution of silyl ether (3R)-35 (503 mg, 1.29 mmol) in THF (13 
mL) at 0 °C under N2 and then the resulting mixture was stirred 
at room temperature. After stirring for 1.5 h, the reaction mixture 
was diluted with EtOAc (40 mL) and washed with water (15 mL) 
and brine (15 mL), and dried over anhydrous Na2SO4. The filtrate 
was concentrated in vacuo, and the residue was purified by 
column chromatography (silica gel, 45% EtOAc in hexane) to 
provide alcohol (3R)-46 (354 mg, 99%) as a colorless oil: [a]D27 
+12.4 (c 1.0, CHCl3); IR (neat, cm–1) ν 3469, 2933, 2889, 2824, 
1639, 1217, 1150, 1110, 1041, 918; 1H NMR (400 MHz, CDCl3) 
δ 5.93 (dddd, J = 16.8, 10.0, 8.2, 6.4 Hz, 1H), 5.11 (d, J = 16.8 
Hz, 1H), 5.10 (d, J = 10.0 Hz, 1H), 4.69 (d, J = 6.4 Hz, 1H), 4.65 
(s, 2H), 4.64 (d, J = 6.4 Hz, 1H), 4.40 (t, J = 6.8 Hz, 1H), 4.27 
(ddd, J = 10.9, 5.2, 2.8 Hz, 1H), 3.80 (dt, J = 12.0, 2.8 Hz, 1H), 
3.54 (d, J = 13.4 Hz, 1H), 3.52 (d, J = 13.4 Hz, 1H), 3.43 (m, 1H), 
3.383 (s, 3H), 3.378 (s, 3H), 2.96 (dd, J = 9.8, 2.8 Hz, 1H), 2.45 
(dd, J = 14.0, 6.4 Hz, 1H), 2.32–2.23 (m, 2H), 2.08 (ddd, J = 12.9, 
8.0, 6.8 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 133.9, 118.0, 
96.6, 96.4, 85.1, 78.6, 77.3, 70.5, 65.3, 55.6, 55.5, 36.9, 
33.9; HRMS (FAB) m/z calcd for C13H25O6 (M+H)+ 277.1651, 
found 277.1652. 
4.3.11. (2R,3R,5S)-3-Methoxymethyloxy-2-
(methoxymethyloxy)methyl-2-allyltetrahydrofuran-5-
carboaldehyde {(3R)-36} 
A solution of DMSO (85 mg, 1.09 mmol) in CH2Cl2 (0.4 mL) 
was dropped to a solution of oxalyl chloride (92 mg, 0.72 mmol) 
in CH2Cl2 (0.8 mL) at –78 °C under N2 over 15 min. A solution 
of alcohol (3R)-46 (100 mg, 0.36 mmol) in CH2Cl2 (0.6 mL) was 
then dropped to the reaction mixture over 15 min. After stirring 
for 30 min at –78 °C, triethylamine (0.25 mL, 1.81 mmol) was 
added to the reaction mixture and the mixture was allowed to 
warm to room temperature over 70 min. After stirred at room 
temperature for 45 min, the reaction mixture was quenched by 
the addition of saturated aqueous NH4Cl (10 mL). The mixture 
was extracted with CH2Cl2 (3 x 15 mL) and combined organic 
layers were dried over anhydrous Na2SO4. The filtrate was 
concentrated in vacuo, and the residue was purified by column 
chromatography (silica gel, 45% EtOAc in hexane) to provide 
aldehyde (3R)-36 (73 mg, 74%) as a colorless oil: [a]D25 –5.1 (c 
1.0, CHCl3); IR (neat, cm–1) ν 3445, 2930, 2890, 2824, 1732, 
1639, 1217, 1150, 1110, 1040, 918; 1H NMR (400 MHz, CDCl3) 
δ 9.68 (d, J = 1.8 Hz, 1H), 5.91 (ddd, J = 17.4, 9.2, 6.9 Hz, 1H), 
5.13 (d, J = 17.4 Hz, 1H), 5.11 (d, J = 9.2 Hz, 1H), 4.69 (d, J = 
6.9 Hz, 1H), 4.65 (d, J = 6.9 Hz, 1H), 4.61 (d, J = 6.9 Hz, 1H), 
4.59 (d, J = 6.9 Hz, 1H), 4.43 (t, J = 7.5 Hz, 1H), 4.24 (dd, J = 
5.6, 4.8 Hz, 1H), 3.51 (d, J = 10.1 Hz, 1H), 3.44 (d, J = 10.1 Hz, 
1H), 3.39 (s, 3H), 3.35 (s, 3H), 2.54 (dd, J = 14.2, 6.4 Hz, 1H), 
2.39 (dd, J = 14.2, 7.1 Hz, 1H), 2.40 (m, 1H), 2.25 (ddd, J = 13.2, 
8.0, 4.6 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 203.0, 133.7, 
118.2, 96.7, 96.1, 87.2, 81.4, 78.7, 70.9, 55.8, 55.4, 36.7, 
34.4; HRMS (EI) m/z calcd for C13H22O6 (M)+ 274.1416, found 
274.1396. 
4.3.12. (4R,5S)-4-Methoxymethyloxy-5-
(methoxymethyloxy)methyl-5-allyltetrahydropyran-1-one {(4R)-
37} 
Catalyst 29 (17 mg, 0.040 mmol, 30 mol%) and DBU (0.005 
mL, 0.027 mmol, 20 mol%) was added to the solution of 
aldehyde (3R)-36 (37 mg, 0.14 mmol) in toluene (2.7 mL) at 
room temperature under N2. After refluxing for 10 h, the reaction 
mixture was quenched by the addition of saturated aqueous 
NH4Cl (3 mL) at room temperature. The mixture was extracted 
with EtOAc (3 x 10 mL) and combined organic layers were dried 
over anhydrous Na2SO4. The filtrate was concentrated in vacuo, 
and the residue was purified by column chromatography (silica 
gel, 40% EtOAc in hexane) to provide lactone (4R)-37 (25 mg, 
68%) as a colorless oil: [a]D24 +13.3 (c 1.0, CHCl3); IR (neat, 
cm–1) ν 2932, 2825, 1738, 1342, 1249, 1214, 1149, 1111, 1037, 
918; 1H NMR (400 MHz, CDCl3) δ 5.90 (dddd, J = 14.4, 11.6, 
8.6, 6.4 Hz, 1H), 5.164 (d, J = 11.6 Hz, 1H), 5.161 (d, J = 14.4 
Hz, 1H), 4.76 (d, J = 7.6 Hz, 1H), 4.70 (d, J = 7.6 Hz, 1H), 4.61 
(s, 2H), 4.02 (dd, J = 6.4, 3.2 Hz, 1H), 3.60 (d, J = 10.6 Hz, 1H), 
3.53 (d, J = 10.6 Hz, 1H), 3.42 (s, 3H), 3.35 (s, 3H), 2.73–2.65 
(m, 2H), 2.57–2.49 (m, 2H), 2.21–2.04 (m, 2H); 13C NMR (100 
MHz, CDCl3) δ 170.2, 131.7, 119.4, 96.8, 96.0, 85.2, 70.9, 69.7, 
56.1, 55.6, 37.9, 26.2, 22.1; HRMS (EI) m/z calcd for C13H22O6 
(M)+ 274.1416, found 274.1440. 
4.3.13. (4R,5S)-4-Methoxymethyloxy-5-
(methoxymethyloxy)methyl-5-(2-undecen-1-yl)tetrahydropyran-1-
one {(4R)-47} 
Grubbs 2nd catalyst (4.0 mg, 0.005 mmol) was added to the 
solution of (4R)-37 (65 mg, 0.23 mmol) and 1-decene (0.45 mL, 
2.37 mmol) in CHCl3 (3.3 mL) at room temperature under N2. 
After refluxing for 4 h, Grubbs 2nd catalyst (2.0 mg, 0.002 
mmol) was added to the reaction mixture and the mixture was 
refluxed for 2 h. Solvent was removed in vacuo, and the residue 
was purified by column chromatography (silica gel, 35% EtOAc 
in hexane) to provide (4R)-47 (66 mg, 72%) as a colorless oil: 
[a]D26 +13.5 (c 1.0, CHCl3); IR (neat, cm–1) ν 2925, 2854, 1741, 
1457, 1248, 1212, 1150, 1111, 1038, 975, 919; 1H NMR (400 
MHz, CDCl3) δ 5.58–5.43 (m, 2H), 4.75 (d, J = 6.8 Hz, 1H), 4.69 
(d, J = 6.8 Hz, 1H), 4.60 (s, 2H), 4.00 (dd, J = 6.0, 3.2 Hz, 1H), 
3.59 (d, J = 10.8 Hz, 1H), 3.52 (d, J = 10.8 Hz, 1H), 3.42 (s, 3H), 
3.35 (s, 3H), 2.72–2.43 (m, 4H), 2.20–2.04 (m, 2H), 2.01 (dd, J = 
13.0, 6.8 Hz, 2H), 1.26 (br s, 12H), 0.88 (t, J = 6.8 Hz, 3H); 13C 
NMR (100 MHz, CDCl3) δ 170.4, 135.7, 134.0, 122.6, 121.9, 
96.8, 96.0, 85.7, 85.4, 71.0, 69.8, 56.1, 55.5, 36.6, 32.6, 31.9, 
31.8, 31.1, 29.4, 29.30, 29.26, 29.2, 29.1, 26.33, 26.27, 22.6, 22.2, 
14.1; HRMS (EI) m/z calcd for C21H38O6 (M)+ 386.2668, found 
386.2682. 
4.3.14. (4R,5S)-4-Methoxymethyloxy-5-
(methoxymethyloxy)methyl-5-undecanyltetrahydropyran-1-one 
{(4R)-38} 
Pd/C {2.2 mg, 10 wt% of (4R)-47} was added to the solution 
of (4R)-47 (22 mg, 0.057 mmol) in MeOH (0.3 mL) at room 
temperature. The reaction mixture was vigorously stirred under 
H2 atmosphere for 10 h. The mixture was filtered through a pad 
of Celite. The filtrate was concentrated in vacuo and the residue 
was purified by column chromatography (silica gel, 35% EtOAc 
in hexane) to provide (4R)-38 (20 mg, 91%) as a colorless oil: 
[a]D26 –15.7 (c 1.0, CHCl3); IR (neat, cm–1) ν 2925, 2854, 1739, 
1466, 1252, 1214, 1150, 1113, 1036, 919; 1H NMR (400 MHz, 
CDCl3) δ 4.74 (d, J = 7.3 Hz, 1H), 4.69 (d, J = 7.3 Hz, 1H), 4.62 
(s, 2H), 4.03 (dd, J = 6.9, 3.2 Hz, 1H), 3.62 (d, J = 10.8 Hz, 1H), 
3.56 (d, J = 10.8 Hz, 1H), 3.41 (s, 3H), 3.36 (s, 3H), 2.67 (dt, J = 
18.3, 7.8 Hz, 1H), 2.52 (dt, J = 18.3, 6.4 Hz, 1H), 2.15 (m, 1H), 
2.05 (dt, J = 13.9, 6.9 Hz, 1H), 1.85–1.72 (m, 2H), 1.51–1.26 (m, 
18H), 0.88 (t, J = 7.3 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 
170.5, 96.8, 95.9, 85.8, 71.0, 69.5, 56.0, 55.6, 33.3, 31.9, 30.2, 
29.60, 29.59, 29.55, 29.5, 29.3, 26.4, 22.7, 22.5, 22.0, 
14.1; HRMS (FAB) m/z calcd for C21H41O6 (M+H)+ 389.2903, 
found 389.2921. 
4.3.15. (4R)-hydroxytanikolide (2) 
6 M HCl (0.23 mL) was added dropwise to the solution of 
MOM ether (4R)-38 (54 mg, 0.14 mmol) in THF (0.7 mL) at 
room temperature. After stirring the reaction mixture at 50 °C for 
3 h, the reaction mixture was quenched by saturated aqueous 
NaHCO3 (2 mL). The mixture was extracted with EtOAc (3 x 10 
mL). Combined organic layers were washed with H2O (10 mL) 
and brine (10 mL), and dried over anhydrous Na2SO4. The filtrate 
concentrated in vacuo, and the residue was purified by column 
chromatography (silica gel, 55% EtOAc in hexane) to provide 
(4R)-hydroxytanikolide (2, 38 mg, 90%) as a white solid: mp 50–
52 °C; [a]D26 –18.1 (c 1.0, CHCl3); IR (KBr, cm–1) ν 3399, 3340, 
2925, 2920, 2849, 1775, 1466, 1196, 1155, 1035; 1H NMR (400 
MHz, CDCl3) δ 4.55 (t, J = 7.6 Hz, 1H), 3.62 (d, J = 11.2 Hz, 
1H), 3.56 (d, J = 11.2 Hz, 1H), 2.64–2.49 (m, 2H), 2.33 (ddd, J = 
18.2, 12.7, 9.2 Hz, 1H), 2.20 (m, 1H), 2.15 (s, 1H), 1.87 (br s, 
1H), 1.68–1.58 (m, 2H), 1.26 (br s, 18H), 0.88 (t, J = 6.8 Hz, 
3H); 13C NMR (100 MHz, CDCl3) δ 177.1, 82.5, 74.5, 63.9, 34.2, 
31.9, 30.2, 29.61, 29.59, 29.57, 29.5, 29.3, 28.9, 23.3, 22.7, 22.2, 
14.1; HRMS (EI) m/z calcd for C17H32O4 (M)+ 300.2301, found 
300.2336. 
4.4. Synthesis of nortanikolide (3) 
4.4.1. (2R,5S)-2-Benzyloxymethyl-5-(tert-
butyldimethylsilyloxy)methyl-2-undecanyltetrahydrofuran (39) 
Potassium bis(trimethylsilyl)amide (KHMDS, 0.5 M in 
toluene, 1.66 mL, 0.83 mmol) was added dropwise to the solution 
of alcohol 25 (166 mg, 0.41 mmol) in THF (4.1 mL) at –20 °C 
under N2. After stirring for 30 min at –20 °C, benzyl bromide 
(0.10 mL, 0.83 mmol) was added to the reaction mixture and the 
mixture was allowed to warm to 0 °C. After stirred at 0 °C for 2 h, 
the reaction mixture was quenched by the addition of saturated 
aqueous Na2CO3 (10 mL). The mixture was extracted with 
EtOAc (3 x 20 mL) and combined organic layers were dried over 
anhydrous Na2SO4. The filtrate was concentrated in vacuo, and 
the residue was purified by column chromatography (silica gel, 
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3% EtOAc in hexane) to provide benzyl ether 39 (178 mg, 88%) 
as a colorless oil: [a]D26 –6.4 (c 1.0, CHCl3); IR (neat, cm–1) ν 
2953, 2926, 2855, 1463, 1254, 1094, 836, 776; 1H NMR (400 
MHz, CDCl3) δ 7.33–7.28 (m, 5H), 4.53 (dd, J = 16.9, 12.4 Hz, 
2H), 4.01 (ddd, J = 12.4, 6.0, 4.6 Hz, 1H), 3.64 (dd, J = 10.5, 4.1 
Hz, 1H), 3.51 (dd, J = 10.5, 6.0 Hz, 1H), 3.31 (s, 2H), 1.98–1.87 
(m, 2H), 1.83–1.66 (m, 2H), 1.56 (m, 2H), 1.25 (br s, 18H) 0.88 
(br s, 12H), 0.032 (s, 3H), 0.027 (s, 3H); 13C NMR (100 MHz, 
CDCl3) δ 138.7, 128.2, 127.5, 127.4, 85.1, 79.9, 75.1, 73.4, 65.9, 
37.3, 32.6, 31.9, 30.3, 29.68, 29.66, 29.6, 29.4, 29.3, 28.4, 25.9, 
24.0, 22.7, 18.4, 14.1, –5.31, –5.33; HRMS (FAB) m/z calcd for 
C30H55O3Si (M+H)+ 491.3921, found 491.3885. 
4.4.2. (2R,5S)-2-Benzyloxymethyl-2-undecanyltetrahydrofuran-5-
methanol (40) 
TBAF (1.0 M in THF, 0.98 mL, 0.98 mmol) was added to a 
solution of silyl ether 39 (456 mg, 0.93 mmol) in THF (9.3 mL) 
at 0 °C under N2 and then the resulting mixture was stirred at 
room temperature. After stirring for 2 h, the reaction mixture was 
diluted with EtOAc (30 mL) and washed with water (15 mL) and 
brine (15 mL), and dried over anhydrous Na2SO4. The filtrate 
was concentrated in vacuo, and the residue was purified by 
column chromatography (silica gel, 17% EtOAc in hexane) to 
provide alcohol 40 (337 mg, 96%) as a colorless oil: [a]D26 +4.2 
(c 1.0, CHCl3); IR (neat, cm–1) ν 3452, 2925, 2853, 1464, 1363, 
1206, 1099, 1077, 1030, 735, 698; 1H NMR (400 MHz, CDCl3) δ 
7.33–7.28 (m, 5H), 4.59 (d, J = 11.9 Hz, 1H), 4.52 (d, J = 11.9 
Hz, 1H), 4.16 (ddd, J = 10.1, 6.6, 3.2 Hz, 1H), 3.79 (dt, J = 11.4, 
3.2 Hz, 1H), 3.47 (d, J = 9.2 Hz, 1H), 3.43 (ddd, J = 11.4, 8.9, 
3.2 Hz, 1H), 3.34 (d, J = 9.2 Hz, 1H), 2.92 (dd, J = 8.9, 3.2 Hz, 
1H), 2.10 (ddd, J = 11.9, 8.5, 6.4 Hz, 1H), 2.04–1.90 (m, 2H), 
1.72 (ddd, J = 11.9, 8.2, 6.9 Hz, 1H), 1.50–1.46 (m, 2H), 1.25 (br 
s, 18H) 0.88 (t, J = 6.9 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 
137.9, 128.4, 127.74, 127.73, 85.4, 80.1, 75.3, 73.5, 65.4, 38.1, 
32.6, 31.9, 30.2, 29.7, 29.60, 29.59, 29.34, 29.31, 27.7, 23.9, 22.7, 
14.1; HRMS (FAB) m/z calcd for C24H41O3 (M+H)+ 377.3056, 
found 377.3030. 
4.4.3. (S)-4-Benzyloxymethyl-4-undecanyltetrahydrofuran-1-one 
(42) and (S)-4-Benzoyloxymethyl-4-undecanyltetrahydrofuran-1-
one (43) 
2-Iodobenzamide 4127 (17.3 mg, 0.06 mmol), additive (none 
or BHT, 13.2 mg, 0.06 mmol) and Oxone○R  (612 mg, 1.00 mmol) 
were added to a solution of tetrahydrofuran-2-methanol 40 (75 
mg, 0.20 mmol) in DMF (1.0 mL) at room temperature. After 
completion of the reaction (checked by TLC), the mixture was 
diluted with EtOAc (20 mL) and quenched by water (10 mL). 
The organic layer was washed by saturated aqueous Na2S2O3 (10 
mL), saturated aqueous NaHCO3 (10 mL), water (10 mL) and 
brine (10 mL), and dried over anhydrous Na2SO4. The filtrate 
was concentrated in vacuo, and the residue was purified by 
column chromatography (silica gel, 10% EtOAc in hexane) to 
provide lactone 42 (no additive: 47 mg, 65%; with BHT: 60 mg, 
83%) as a colorless oil and side product 43 (no additives: 9 mg, 
12%; with BHT: trace) as a colorless oil. 42: [a]D22 +2.7 (c 1.0, 
EtOH); IR (neat, cm–1) ν 2925, 2854, 1774, 1455, 1203, 1162, 
1115, 942, 738, 698; 1H NMR (400 MHz, CDCl3) δ 7.37–7.27 (m, 
5H), 4.58 (d, J = 11.9 Hz, 1H), 4.51 (d, J = 11.9 Hz, 1H), 3.53 (d, 
J = 10.1 Hz, 1H), 3.47 (d, J = 10.1 Hz, 1H), 2.72 (ddd, J = 18.0, 
10.5, 8.7 Hz, 1H), 2.49 (ddd, J = 18.0, 10.5, 4.6 Hz, 1H), 2.26 
(ddd, J = 12.8, 10.5, 4.6 Hz, 1H), 1.98 (ddd, J = 12.8, 10.5, 8.7 
Hz, 1H), 1.67–1.62 (m, 2H), 1.25 (br s, 18H) 0.88 (t, J = 6.9 Hz, 
3H); 13C NMR (100 MHz, CDCl3) δ 177.4, 137.8, 128.6, 127.8, 
127.5, 87.7, 74.8, 73.6, 37.2, 31.9, 29.9, 29.64, 29.58, 29.5, 29.4, 
29.32, 29.28, 28.8, 23.1, 22.7, 14.1, –0.02; HRMS (EI) m/z calcd 
for C23H36O3 (M)+ 360.2665, found 360.2645. 43: [a]D26 +6.1 (c 
1.0, CHCl3); IR (neat, cm–1) ν 2925, 2854, 1778, 1725, 1271, 
1114, 943, 712; 1H NMR (400 MHz, CDCl3) δ 8.00 (dd, J = 6.9, 
1.4 Hz, 2H), 7.59 (dd, J = 7.3, 1.4 Hz, 1H), 7.46 (dd, J = 7.3, 6.9 
Hz, 2H), 4.45 (d, J = 11.9 Hz, 1H), 4.35 (d, J = 11.9 Hz, 1H), 
2.73 (ddd, J = 18.3, 10.5, 8.2 Hz, 1H), 2.62 (ddd, J = 18.3, 10.5, 
5.0 Hz, 1H), 2.26 (ddd, J = 13.3, 10.5, 5.0 Hz, 1H), 2.14 (ddd, J 
= 13.3, 10.5, 8.2 Hz, 1H), 1.82–1.78 (m, 2H), 1.47–1.39 (m, 2H), 
1.38–1.28 (m, 5H), 1.26 (br s, 11H) 0.88 (t, J = 6.9 Hz, 3H); 13C 
NMR (100 MHz, CDCl3) δ 176.5, 166.1, 133.4, 129.6, 128.6, 
86.3, 68.5, 37.2, 31.9, 29.8, 29.59, 29.57, 29.5, 29.4, 29.31, 29.27, 
29.2, 28.5, 23.1, 22.7, 14.1 ; HRMS (EI) m/z calcd for C23H34O4 
(M)+ 374.2457, found 374.2454. 
4.4.4. nortanikolide (3) 
Pd(OH)2/C (2.3 mg, 10 wt% of 42) was added to the solution 
of 42 (23 mg, 0.06 mmol) in MeOH (0.8 mL) at room 
temperature. The reaction mixture was vigorously stirred under 
H2 for 4 h. The mixture was filtered through a pad of Celite. The 
filtrate was concentrated in vacuo and the residue was purified by 
column chromatography (silica gel, 45% EtOAc in hexane) to 
provide nortanikolide (3, 16 mg, 94%) as a white solid: mp 43–
44 °C; [a]D22 +9.8 (c 1.0, EtOH); IR (KBr, cm–1) ν 3427, 2955, 
2917, 2848, 1749, 1469, 1297, 1218, 1078, 1048, 934; 1H NMR 
(400 MHz, CDCl3) δ 3.75 (dd, J = 12.0, 5.2 Hz, 1H), 3.54 (dd, J 
= 12.0, 3.6 Hz, 1H), 2.70 (ddd, J = 17.9, 10.7, 7.2 Hz, 1H), 2.58 
(ddd, J = 17.9, 10.7, 6.4 Hz, 1H), 2.04–1.96 (m, 2H), 1.66 (br t, J 
= 7.6 Hz, 1H), 1.30 (br s, 5H), 1.25 (br s, 15H) 0.88 (t, J = 6.8 Hz, 
3H); 13C NMR (100 MHz, CDCl3) δ 177.4, 87.8, 67.4, 36.4, 31.9, 
29.9, 29.6, 29.54, 29.50, 29.3, 27.4, 23.1, 22.7, 14.1; HRMS (EI) 
m/z calcd for C16H30O3 (M)+ 270.2195, found 270.2162. 
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